RAFFA WEALTH MANAGEMENT, LLC’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$61.6K Buy
1,069
+34
+3% +$1.95K 0.01% 158
2026
Q1
$62.8K Buy
1,035
+11
+1% +$641 0.01% 148
2025
Q4
$55.2K Hold
1,024
0.01% 156
2025
Q3
$46.2K Sell
1,024
-704
-41% -$32.9K 0.01% 166
2025
Q2
$80K Buy
1,728
+717
+71% +$35.2K 0.02% 141
2025
Q1
$61.7K Sell
1,011
-90
-8% -$5.25K 0.01% 136
2024
Q4
$62.3K Buy
1,101
+40
+4% +$2.23K 0.01% 136
2024
Q3
$54.9K Hold
1,061
0.01% 140
2024
Q2
$44.1K Hold
1,061
0.01% 206
2024
Q1
$57.5K Sell
1,061
-32
-3% -$1.63K 0.02% 183
2023
Q4
$56.1K Hold
1,093
0.02% 128
2023
Q3
$63.4K Hold
1,093
0.02% 111
2023
Q2
$69.9K Sell
1,093
-200
-15% -$13.4K 0.02% 106
2023
Q1
$89.6K Hold
1,293
0.03% 106
2022
Q4
$93K Sell
1,293
-171
-12% -$12.9K 0.04% 93
2022
Q3
$104K Buy
1,464
+11
+0.8% +$798 0.05% 80
2022
Q2
$112K Hold
1,453
0.05% 84
2022
Q1
$106K Hold
1,453
0.04% 86
2021
Q4
$90.6K Sell
1,453
-15
-1% -$880 0.03% 103
2021
Q3
$86.9K Buy
1,468
+51
+4% +$3.36K 0.03% 84
2021
Q2
$94.7K Sell
1,417
-1,107
-44% -$72.2K 0.03% 82
2021
Q1
$159K Buy
2,524
+41
+2% +$2.55K 0.06% 76
2020
Q4
$154K Buy
2,483
+35
+1% +$2.15K 0.05% 75
2020
Q3
$148K Sell
2,448
-168
-6% -$10.1K 0.06% 70
2020
Q2
$154K Buy
2,616
+18
+0.7% +$1.08K 0.06% 68
2020
Q1
$145K Sell
2,598
-282
-10% -$17.2K 0.05% 65
2019
Q4
$185K Buy
2,880
+1,287
+81% +$73.7K 0.06% 79
2019
Q3
$80.8K Buy
+1,593
New +$74.9K 0.03% 100
2019
Q2
Sell
-840
Closed -$40.1K 824
2019
Q1
$40.1K Hold
840
0.02% 125
2018
Q4
$43.7K Hold
840
0.02% 136
2018
Q3
$52.1K Hold
840
0.02% 136
2018
Q2
$46.5K Hold
840
0.02% 133
2018
Q1
$53.1K Buy
840
+123
+17% +$7.91K 0.02% 118
2017
Q4
$43.9K Hold
717
0.02% 133
2017
Q3
$45.7K Hold
717
0.02% 136
2017
Q2
$40K Hold
717
0.02% 135
2017
Q1
$39K Sell
717
-36
-5% -$1.98K 0.02% 115
2016
Q4
$44K Buy
753
+100
+15% +$5.47K 0.02% 102
2016
Q3
$35.2K Hold
653
0.02% 106
2016
Q2
$48K Hold
653
0.03% 85
2016
Q1
$41.7K Sell
653
-63
-9% -$3.97K 0.02% 106
2015
Q4
$49.3K Hold
716
0.03% 87
2015
Q3
$42.4K Hold
716
0.03% 98
2015
Q2
$47.6K Hold
716
0.03% 93
2015
Q1
$46.2K Buy
716
+63
+10% +$3.94K 0.03% 84
2014
Q4
$38.5K Sell
653
-500
-43% -$28.2K 0.02% 91
2014
Q3
$59K Buy
1,153
+136
+13% +$6.79K 0.04% 70
2014
Q2
$49.3K Hold
1,017
0.04% 80
2014
Q1
$52.8K Buy
1,017
+364
+56% +$19.4K 0.04% 74
2013
Q4
$38.5K Buy
+653
New +$33.3K 0.02% 91

Other funds holding BMY

RAFFA WEALTH MANAGEMENT, LLC's BMY Position: Q2 2026 in Review

RAFFA WEALTH MANAGEMENT, LLC increased its Bristol-Myers Squibb (BMY) stake by 3.3% in Q2 2026, buying an estimated $1.95K and bringing the position to 1,069 shares worth $61.6K. The position accounts for 0.01% of the portfolio, ranked #158.

RAFFA WEALTH MANAGEMENT, LLC first reported a position in BMY in Q4 2013 and has held it in 50 quarters since. The position peaked at $185K in Q4 2019. 889 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • RAFFA WEALTH MANAGEMENT, LLC held 1,069 shares of Bristol-Myers Squibb worth $61.6K as of Q2 2026.
  • RAFFA WEALTH MANAGEMENT, LLC bought 34 Bristol-Myers Squibb shares in Q2 2026, an estimated $1.95K.
  • Bristol-Myers Squibb made up 0.01% of RAFFA WEALTH MANAGEMENT, LLC's portfolio in Q2 2026, its #158 holding.
  • RAFFA WEALTH MANAGEMENT, LLC first reported a position in Bristol-Myers Squibb in Q4 2013 and has held it in 50 quarters since.
  • RAFFA WEALTH MANAGEMENT, LLC's Bristol-Myers Squibb position peaked at $185K in Q4 2019.
  • 889 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on RAFFA WEALTH MANAGEMENT, LLC's 13F filing for Q2 2026, filed 27 Jul 2026.